Dehydrocostus lactone enhances tumor necrosis factor-α-induced apoptosis of human leukemia HL-60 cells

Immunopharmacology and Immunotoxicology

Volumn 26, Issue 2, 2004, Pages 163-175

  Oh, G S ^a   Pae, H O ^a   Chung, H T ^a   Kwon, J W ^a   Lee, J H ^a   Kwon, T O ^a   Kwon, S Y ^a   Chon, B H ^a   Yun, Young Gab ^a,b  

^a Wonkwang University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Dehydrocostus lactone (DL); Human leukemia HL 60 cells; Nuclear transcription factor B (NF B); TNF induced apoptosis

Indexed keywords

CASPASE 3; CASPASE 8; DEHYDROCOSTUS LACTONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTONE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SAUSSUREA LAPPA EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CONCENTRATION RESPONSE; DRUG DNA BINDING; DRUG ISOLATION; HUMAN; HUMAN CELL; PLANT ROOT; PRIORITY JOURNAL; SAUSSUREA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASES; DRUG SYNERGISM; HL-60 CELLS; HUMANS; LACTONES; NEOPLASM PROTEINS; NF-KAPPA B; PHYTOTHERAPY; SAUSSUREA; SESQUITERPENES; TUMOR NECROSIS FACTOR-ALPHA;

SAUSSUREA;

EID: 2942511233     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120037712     Document Type: Article

References (17)

1. Matsuda, H.; Toguchida, I.; Ninomiya, K.; Kageura, T.; Morikawa, T.; Yoshikawa, M. Effects of sesquiterpenes and amino acid-sesquiterpene conjugates from the roots of Saussurea lappa on inducible nitric oxide synthase and heat shock protein in lipopolysaccharide-activated macrophages. Bioorg. Med. Chem. 2003, 11 (5), 709-715.
2. Zingarelli, B.; Sheehan, M.; Wong, H.R. Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit. Care Med. 2003, 31 (1), S105-S111.
3. Kucharczak, J.; Simmons, M.J.; Fan, Y.; Gelinas, C. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003, 22 (56), 8961-8982.
4. Aggarwal, B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev., Immunol. 2003, 3 (9), 745-756.
5. Wajant, H.; Pfizenmaier, K.; Scheurich, P. Tumor necrosis factor signaling. Cell Death Differ. 2003, 10 (1), 45-65.
6. Lee, K.Y.; Park, J.S.; Jee, Y.K.; Rosen, G.D. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation. Exp. Mol. Med. 2002; 34 (6), 462-468.
7. Thomas, R.P.; Farrow, B.J.; Kim, S.; May, M.J.; H[ellmich, M.R.; Evers, B.M. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death. Surgery 2002, 132 (2), 127-134.
8. Mitsiades, N.; Mitsiades, C.S.; Poulaki, V.; Chauhan, D.; Richardson, P.G.; Hideshima, T.; Munshi, N.C.; Treon, S.P.; Anderson, K.C. Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications. Blood 2002, 99 (12), 4525-4530.
9. Dhanalakshmi, S.; Singh, R.P.; Agarwal, C.; Agarwal, R. Silibinin inhibits constitutive and TNF-alpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNF-alpha-induced apoptosis. Oncogene 2002, 21 (11), 1759-1767.
10. McDade, T.P.; Perugini, R.A.; Vittimberga, F.J.; Carrigan, R.C.; Callery, M.P. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. J. Surg. Res. 1999, 83 (1), 56-61.
11. Lee, H.J.; Kim, N.Y.; Jang, M.K.; Son, H.J.; Kim, K.M.; Sohn, D.H.; Lee, S.H.; Ryu, J.H. A sesquiterpene, dehydrocostus lactone, inhibits the expression of inducible nitric oxide synthase and TNF-alpha in LPS-activated macrophages. Planta Med. 1999, 65 (2), 104-108.
12. Secchiero, P.; Milani, D.; Gonelli, A.; Melloni, E.; Campioni, D.; Gibellini, D.; Capitani, S.; Zauli, G. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells. J. Leukoc. Biol. 2003, 74 (2), 223-232.
13. Beyaert, R.; Heyninck, K.; Van Huffel, S. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappaB-dependent gene expression and apoptosis. Biochem. Pharmacol. 2000, 60 (8), 1143-1151.
14. Schwartz, S.A.; Hernandez, A.; Mark, E.B. The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies. Surg. Oncol. 1999, 8 (3), 143-153.
15. Mitsiades, N.; Mitsiades, C.S.; Poulaki, V.; Chauhan, D.; Richardson, P.G.; Hideshima, T.; Munshi, N.; Treon, S.P.; Anderson, K.C. Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. Blood 2002, 99 (11), 4079-4086.
16. Oya, M.; Ohtsubo, M.; Takayanagi, A.; Tachibana, M.; Shimizu, N.; Murai, M. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene 2001, 20 (29), 3888-3896.
17. Figueroa, Y.G.; Chan, A.K.; Ibrahim, R.; Tang, Y.; Burow, M.E.; Alam, J. ; Scandurro, A.B.; Beckman, B.S. NF-kappaB plays a key role in hypoxia-inducible factor-I-regulated erythropoietin gene expression. Exp. Hematol. 2002, 30 (12), 1419-1427.